Skip to main content
. Author manuscript; available in PMC: 2012 Nov 15.
Published in final edited form as: Exp Cell Res. 2011 Jun 17;317(19):2732–2739. doi: 10.1016/j.yexcr.2011.06.002

Fig 1.

Fig 1

Properties of mutant K-RAS revealed by analysis of isogenic human CRC cell line pairs. Oncogenic K-RAS engages both pro-tumorigenic pathways (shaded in blue) and, paradoxically, anti-tumorigenic pathways (shaded in red). Arrows represent both direct and indirect interactions.